These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 37013524)

  • 41. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increases in housing rules and surveillance during COVID-19: impacts on overdose and overdose response in a community-based cohort of sex workers who use drugs in Vancouver, BC.
    McDermid J; Pearson J; Braschel M; Moreheart S; Marck R; Shannon K; Krüsi A; Goldenberg SM
    Harm Reduct J; 2024 Aug; 21(1):153. PubMed ID: 39175071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
    Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
    Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors associated with obtaining prescribed safer supply among people accessing harm reduction services: findings from a cross-sectional survey.
    Palis H; Haywood B; McDougall J; Xavier CG; Desai R; Tobias S; Burgess H; Ferguson M; Liu L; Kinniburgh B; Slaunwhite AK; Crabtree A; Buxton JA
    Harm Reduct J; 2024 Jan; 21(1):5. PubMed ID: 38184576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data.
    Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. "There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada.
    Xavier J; Greer A; Pauly B; Loyal J; Mamdani Z; Ackermann E; Barbic S; Buxton JA
    Int J Drug Policy; 2022 Jul; 105():103714. PubMed ID: 35561485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
    Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
    Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using linked data to identify pathways of reporting overdose events in British Columbia, 2015-2017.
    Graham E; Zhao B; Flynn M; Gustafson P; Irvine MA; Slaunwhite A; Orpana H; Kuo M; MacDougall L
    Int J Popul Data Sci; 2022; 7(1):1708. PubMed ID: 37650030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intention to seek emergency medical services during community overdose events in British Columbia, Canada: a cross-sectional survey.
    Kievit B; Xavier JC; Ferguson M; Palis H; Moallef S; Slaunwhite A; Gillis T; Virk R; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):56. PubMed ID: 35883186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between toxic drug events and encephalopathy in British Columbia, Canada: a cross-sectional analysis.
    Xavier CG; Kuo M; Desai R; Palis H; Regan G; Zhao B; Moe J; Scheuermeyer FX; Gan WQ; Sabeti S; Meilleur L; Buxton JA; Slaunwhite AK
    Subst Abuse Treat Prev Policy; 2023 Jul; 18(1):42. PubMed ID: 37420239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opportunities and challenges for implementing drug checking services in British Columbia, Canada: A qualitative study.
    Chayama KL; Ti L; Arredondo Sanchez Lira J; Coulaud PJ; Bardwell G; Knight R
    Int J Drug Policy; 2024 Oct; 132():104560. PubMed ID: 39217815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.